Cargando…
The IL-33/sST2 Axis in Thromboangiitis Obliterans
BACKGROUND: Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated. METHODS: The serum level of IL-33 and sST2 in 50 TAO pa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371438/ https://www.ncbi.nlm.nih.gov/pubmed/32765040 http://dx.doi.org/10.2147/JIR.S253980 |
_version_ | 1783561120942915584 |
---|---|
author | Sharebiani, Hiva Mohareri, Mehran Mirhosseini, Ali Fazeli, Bahare |
author_facet | Sharebiani, Hiva Mohareri, Mehran Mirhosseini, Ali Fazeli, Bahare |
author_sort | Sharebiani, Hiva |
collection | PubMed |
description | BACKGROUND: Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated. METHODS: The serum level of IL-33 and sST2 in 50 TAO patients, 20 age- and smoking habit-matched controls and 19 age-matched non-smoker controls was evaluated. RESULTS: The mean level of IL-33 in TAO, smokers and non-smokers was 370.2±61.7ng/mL,132.14±2.6ng/mL and 11.3±0.38ng/mL, respectively. The IL-33 was significantly higher in the TAO than in either control groups (p < 0.001). The IL-33 in the acute phase of TAO was significantly higher than in the patients in the quiescent phase of the disease (p = 0.019). Also, IL-33 in the patients with gangrene was significantly higher than in the patients with non-healing ulcers (p = 0.021). The sST2 in the TAO patients was 49.3±5.58ng/mL, and in smoker and non-smoker controls, it was 45.3±6.3ng/mL and 4.11±0.17ng/mL, respectively. No significant difference was found between the patients and smoker control groups (p = 0.87). The mean ratio of IL-33/sST2 was 27.89±10.44 in the TAO group and, in smokers and non-smokers, it was 2.85±0.48 and 2.84±0.14, respectively. A significantly high level of IL-33/sST2 ratio was observed in TAO patients in both the active and quiescent phases of the disease in comparison to both control groups (p<0.001). CONCLUSION: The regulation pattern of IL-33/sST2 was different in TAO in comparison to autoimmune vasculitis. |
format | Online Article Text |
id | pubmed-7371438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-73714382020-08-05 The IL-33/sST2 Axis in Thromboangiitis Obliterans Sharebiani, Hiva Mohareri, Mehran Mirhosseini, Ali Fazeli, Bahare J Inflamm Res Original Research BACKGROUND: Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated. METHODS: The serum level of IL-33 and sST2 in 50 TAO patients, 20 age- and smoking habit-matched controls and 19 age-matched non-smoker controls was evaluated. RESULTS: The mean level of IL-33 in TAO, smokers and non-smokers was 370.2±61.7ng/mL,132.14±2.6ng/mL and 11.3±0.38ng/mL, respectively. The IL-33 was significantly higher in the TAO than in either control groups (p < 0.001). The IL-33 in the acute phase of TAO was significantly higher than in the patients in the quiescent phase of the disease (p = 0.019). Also, IL-33 in the patients with gangrene was significantly higher than in the patients with non-healing ulcers (p = 0.021). The sST2 in the TAO patients was 49.3±5.58ng/mL, and in smoker and non-smoker controls, it was 45.3±6.3ng/mL and 4.11±0.17ng/mL, respectively. No significant difference was found between the patients and smoker control groups (p = 0.87). The mean ratio of IL-33/sST2 was 27.89±10.44 in the TAO group and, in smokers and non-smokers, it was 2.85±0.48 and 2.84±0.14, respectively. A significantly high level of IL-33/sST2 ratio was observed in TAO patients in both the active and quiescent phases of the disease in comparison to both control groups (p<0.001). CONCLUSION: The regulation pattern of IL-33/sST2 was different in TAO in comparison to autoimmune vasculitis. Dove 2020-07-16 /pmc/articles/PMC7371438/ /pubmed/32765040 http://dx.doi.org/10.2147/JIR.S253980 Text en © 2020 Sharebiani et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Sharebiani, Hiva Mohareri, Mehran Mirhosseini, Ali Fazeli, Bahare The IL-33/sST2 Axis in Thromboangiitis Obliterans |
title | The IL-33/sST2 Axis in Thromboangiitis Obliterans |
title_full | The IL-33/sST2 Axis in Thromboangiitis Obliterans |
title_fullStr | The IL-33/sST2 Axis in Thromboangiitis Obliterans |
title_full_unstemmed | The IL-33/sST2 Axis in Thromboangiitis Obliterans |
title_short | The IL-33/sST2 Axis in Thromboangiitis Obliterans |
title_sort | il-33/sst2 axis in thromboangiitis obliterans |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371438/ https://www.ncbi.nlm.nih.gov/pubmed/32765040 http://dx.doi.org/10.2147/JIR.S253980 |
work_keys_str_mv | AT sharebianihiva theil33sst2axisinthromboangiitisobliterans AT moharerimehran theil33sst2axisinthromboangiitisobliterans AT mirhosseiniali theil33sst2axisinthromboangiitisobliterans AT fazelibahare theil33sst2axisinthromboangiitisobliterans AT sharebianihiva il33sst2axisinthromboangiitisobliterans AT moharerimehran il33sst2axisinthromboangiitisobliterans AT mirhosseiniali il33sst2axisinthromboangiitisobliterans AT fazelibahare il33sst2axisinthromboangiitisobliterans |